You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Bergwerk Dov · SEC Form 4 · Filed Nov 6, 2026
Sale
Calculated transaction value
$365.26K
Bergwerk Dov Interim Cheif Legal Officer
TEVA
Transaction date
Nov 4, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 2 days later
TEVA daily price context
Close on/before transaction
$41.85
Nov 4, 2026
First close after public filing
$42.97
Nov 9, 2026
Return after filing · so far
+0.63%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 8,755 shares @ $41.72
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-451804
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.96M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Nov 4, 2026 | $0 |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Nov 4, 2026 | $253.72K |
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Nov 4, 2026 | $365.26K |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Nov 4, 2026 | $0 |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Nov 4, 2026 | $607.42K |
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Nov 4, 2026 | $730.31K |